{"id":"W4327676480","doi":"10.1007/s13555-023-00910-6","title":"Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA","year":2023,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Secukinumab; Medicine; Discontinuation; Ixekizumab; Adalimumab; Psoriasis; Psoriasis Area and Severity Index; Psoriatic arthritis; Ustekinumab; Cohort; Dermatology; Internal medicine; Pediatrics; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001169414,0.00008924886,0.0002168484,0.0004387742,0.000235723,0.0006540667,0.0001841273,0.0002076377,0.001280209],"category_scores_gemma":[0.00230135,0.000079283,0.0004239967,0.001115125,0.0001873299,0.0002784549,0.0002832108,0.000515099,0.0001539031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008681514,"about_ca_system_score_gemma":0.0007395938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01134058,"about_ca_topic_score_gemma":0.01629,"domain_scores_codex":[0.9992371,0.0002051858,0.0000831113,0.0001468992,0.0002249295,0.0001028599],"domain_scores_gemma":[0.9974682,0.0004202095,0.00140393,0.00008988336,0.0002743324,0.0003433782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002138967,0.0002389078,0.9568548,0.00009014941,0.0003683278,0.0001168943,0.00009583194,0.0001901935,0.0004164675,0.0001163298,0.003071393,0.0363018],"study_design_scores_gemma":[0.000145469,0.000432183,0.9944593,0.00005931949,0.0002275361,0.000283922,0.0001041358,0.0004560412,0.0002456887,0.00007879335,0.00350094,0.000006752049],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990041,0.004204638,0.0002009914,0.0007749173,0.00002941648,0.00001790899,0.002537272,0.00001213513,0.002181879],"genre_scores_gemma":[0.997016,0.0007365944,0.00008067845,0.0002271333,0.00004186752,0.0000133677,0.00158535,0.000003229496,0.0002958862],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01134058,"threshold_uncertainty_score":0.02254915,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02286308285646909,"score_gpt":0.2595506901935598,"score_spread":0.2366876073370907,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}